Skip to main content

Table 1 LOI and MOI in hiPSCs

From: Stability of genomic imprinting in human induced pluripotent stem cells

  

H19

IGF2

PEG3

PEG1

GTL2

KCNQ1

NDN

LIT1

  

(RsaI)

(ApaI)

(MnlI)

(AflIII)

(TaaI)

(SmaI)

(MboI)

(RsaI)

Cell

Passage

gDNA

cDNA

gDNA

cDNA

gDNA

cDNA

gDNA

cDNA

gDNA

cDNA

gDNA

cDNA

gDNA

cDNA

gDNA

cDNA

AM936EP

P9

a/b

a

b

-

a

-

b

-

a/b

a

a

-

b

-

a/b

a

AM-iPS -2

P13

a/b

a

b

-

a

-

b

-

a/b

a

a

-

b

-

a/b

a

AM-iPS -2

P19

a/b

a

b

-

a

-

b

-

a/b

a

a

-

b

-

a/b

a

AM-iPS -2

P35

a/b

a

b

-

a

-

b

-

a/b

a

a

-

b

-

a/b

a

AM-iPS -3

P9

a/b

a

b

-

a

-

b

-

a/b

a

a

-

b

-

a/b

a

AM-iPS -3

P21

a/b

a

b

-

a

-

b

-

a/b

a

a

-

b

-

a/b

a

AM-iPS -3

P29

a/b

b

b

-

a

-

b

-

a/b

a

a

-

b

-

a/b

a

AM-iPS -3

P36

a/b

a

b

-

a

-

b

-

a/b

a

a

-

b

-

a/b

a

AM-iPS -7

P12

a/b

a

b

-

a

-

b

-

a/b

a/b

a

-

b

-

a/b

a

AM-iPS -7

P22

a/b

a

b

-

a

-

b

-

a/b

a/b

a

-

b

-

a/b

a

AM-iPS -7

P32

a/b

a

b

-

a

-

b

-

a/b

a/b

a

-

b

-

a/b

a

AM-iPS -8

P13

a/b

a

b

-

a

-

b

-

a/b

a

a

-

b

-

a/b

a

AM-iPS -8

P20

a/b

a

b

-

a

-

b

-

a/b

a

a

-

b

-

a/b

a

AM-iPS -8

P37

a/b

a

b

-

a

-

b

-

a/b

a

a

-

b

-

a/b

a

AM-iPS -20

P8

N.T.

a

N.T.

-

N.T.

-

N.T.

-

N.T.

a

N.T.

-

N.T.

-

N.T.

a

AM-iPS -20

P11

a/b

a

b

-

a

-

b

-

a/b

a

a

-

b

-

a/b

a

AM-iPS -20

P14

a/b

a

b

-

a

-

b

-

a/b

a

a

-

b

-

a/b

a

AM-iPS -20

P16

a/b

N.D.

b

-

a

-

b

-

a/b

a

a

-

b

-

a/b

a

AM-iPS -20

P32

a/b

N.D.

b

-

a

-

b

-

a/b

a

a

-

b

-

a/b

a

PL551Ar

P16

a/b

a

a/b

a

b

-

a/b

N.D.

b

-

b

N.D.

a

-

a

-

PAE-iPS -05

P19

a/b

a

a/b

N.D.

b

-

a/b

N.D.

b

-

b

-

a

-

a

-

PAE-iPS -05

P31

a/b

a

a/b

N.D.

b

-

a/b

N.D.

b

-

b

-

a

-

a

-

PAE-iPS -11

P14

a/b

a

a/b

N.D.

b

-

a/b

N.D.

b

-

b

-

a

-

a

-

PAE-iPS -11

P18

a/b

a

a/b

N.D.

b

-

a/b

N.D.

b

-

b

-

a

-

a

-

PAE-iPS -11

P30

a/b

a

a/b

N.D.

b

-

a/b

N.D.

b

-

b

-

a

-

a

-

MRC-5

-

a/b

N.D.

b

-

a

-

b

-

a/b

a/b

a/b

N.D.

a/b

N.D.

a

-

MRC-iPS -16

P30

a/b

N.D.

b

-

a

-

b

-

a/b

ND

a/b

b

a/b

a

a

-

MRC-iPS -25

P6

a/b

N.D.

b

-

a

-

b

-

a/b

ND

a/b

b

a/b

a

a

-

MRC-iPS -25

P30

a/b

N.D.

b

-

a

-

b

-

a/b

ND

a/b

b

a/b

a

a

-

MRC-iPS -40

P11

a/b

N.D.

b

-

a

-

b

-

a/b

ND

a/b

b

a/b

a

a

-

MRC-iPS -40

P30

a/b

N.D.

b

-

a

-

b

-

a/b

ND

a/b

b

a/b

a

a

-

UtE1104

P9

a/b

N.D.

a

-

a/b

a/b

a/b

b

a/b

a/b

b

N.D.

b

-

a

-

UtE-iPS -6

P20

a/b

N.D.

a

-

a/b

a/b

a/b

a/b

a/b

a/b

b

-

b

-

a

-

UtE-iPS -6

P31

a/b

b

a

-

a/b

a/b

a/b

a/b

a/b

a/b

b

-

b

-

a

-

UtE-iPS -11

P13

a/b

N.D.

a

-

a/b

N.D.

a/b

a/b

a/b

a

b

N.D.

b

-

a

-

UtE-iPS -11

P20

a/b

N.D.

a

-

a/b

N.D.

a/b

a/b

a/b

a/b

b

N.D.

b

-

a

-

UtE-iPS -11

P30

a/b

N.D.

a

-

a/b

N.D.

a/b

a/b

a/b

a

b

-

b

-

a

-

Edom22

P5

b

-

a/b

a/b

a

-

a/b

b

b

-

a/b

a

a

-

a

-

Edom-iPS -1

P27

b

-

a/b

N.D.

a

-

a/b

b

b

-

a/b

a

a

-

a

-

hES 3

P29

a/b

a

b

-

a/b

a

a/b

b

b

-

a

-

a/b

b

a

-

SEES 1

P10

a/b

a

a/b

a

a

-

b

-

a/b

b

a

-

a

-

a

-

SEES 4

P9

a/b

b

a/b

a

a

-

b

-

b

-

a

-

a/b

b

a

-

  1. A summary of LOI and MOI RFLP data for the 8 imprinted genes analyzed in 22 hiPSCs and 3 control hES cell lines. hiPSCs derived from extraembryonic amniotic membrane (AM-iPS), embryonic lung tissue (MRC-iPS), uterine endometrium (UtE-iPS), adult menstrual blood (Edom-iPS) and extraembryonic placental tissue (PAE-iPS). Samples were analyzed at the specified passage number. (-): not informative.